GlaxoSmithKline Seeks to Sell Flu Vaccine in U.S.
- Share via
From Associated Press
GlaxoSmithKline is hoping to enter the U.S. flu-vaccine market, citing the nationwide shortage last year that led to lines for the vaccines.
The company applied to the Food and Drug Administration for permission to sell Fluarix, which is sold in more than 75 countries.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
